Citation: | MA Li, ZHANG Menghan, XU Zhiwei, SUN Ying′ai, ZHU Jing, HUANG Yingbo, ZHANG Dayong. A new synthetic process of dapagliflozin[J]. Journal of China Pharmaceutical University, 2017, 48(1): 42-45. DOI: 10.11665/j.issn.1000-5048.20170106 |
[1] |
Tang Q,Li X,Song P,et al.Optimal cut-off values for the homeostasis model assessment of insulin resistance(HOMA-IR)and pre-diabetes screening:developments in research and prospects for the future[J].Drug Discov Ther,2015,9(6):380-384.
|
[2] |
Mather A,Pollock C.Glucose handling by the kidney[J].Kidney Int Suppl,2011,79(2):S1-S6.
|
[3] |
Meng W,Ellsworth BA,Nirschl AA,et al.Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2(SGLT2)inhibitor for the treatment of type 2 diabetes[J].J Med Chem,2008, 51(5):1145-1149.
|
[4] |
Xu BH,Lv BH,Xu G,et al.Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2(SGLT2)inhibitors:WO,2013152476[P].2013-10-17.
|
[5] |
Lemaire S,Houpis IN,Xiao T,et al.Stereoselective C-glycosylation reactions with arylzinc reagents[J].Org Lett,2012, 14(6):1480-1483.
|
[6] |
Zhang WW,Dai ZQ,Zhang ZY,et al.Progress in transition-metal-catalyzed cross-coupling reaction of grignard reagent with halides[J].Chem World(化学世界),2001,52(3):314-316.
|